It is a trading private limited company based in New Delhi, Delhi, India, established in 2018.
2018 | New Delhi, Delhi, India | ActiveSubzone Pharmaceuticals Private Limited, a active private limited company, was established on 20 July 2018 in New Delhi, Delhi, India. Engaging in specialty within the trading sector, it holds CIN: U51909DL2018PTC336828. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.50 M.
Its leadership includes Jay Shankar Mishra (Director), Chandan Kumar Jha (Additional Director), Ranjeet Jha (Director). Past directors included Amrendra Kumar Jha. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No. 20, Kh. No. 1079, Ground Floor Prem Nagar-2, Blk-N, Suleman Nagar,, New Delhi, Delhi, 110086.
U51909DL2018PTC336828
336828
20 July 2018
₹1.00 M
₹0.50 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Subzone Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jay Shankar Mishra | Director | 20 Jul 2018 | Current |
| Chandan Kumar Jha | Additional Director | 23 Sep 2022 | Current |
| Ranjeet Jha | Director | 12 Jul 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 12 Jul 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Subzone Pharmaceuticals Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 4.54% increase. The company also saw a substantial fall in profitability, with a 34.94% decrease in profit. The company's net worth moved up by a moderate rise of 0.19%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Subzone Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Subzone Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Subzone Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Subzone Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Subzone Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Subzone Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
Progress on Chandan Kumar Jha was appointed as a Additional Director was appointed as a Additional Director on 23 Sep 2022 & has been associated with this company since 3 years 3 months . was documented.
The activity Ranjeet Jha was appointed as a Director was appointed as a Director on 12 Jul 2019 & has been associated with this company since 6 years 5 months . was completed.
The activity Jay Shankar Mishra was appointed as a Director was appointed as a Director on 20 Jul 2018 & has been associated with this company since 7 years 5 months . was completed.
The activity Subzone Pharmaceuticals Private Limited was registered on 20 Jul 2018 with Roc Delhi & aged 7 years 5 months as per MCA records. was completed.
The CIN of Subzone Pharmaceuticals Private Limited is U51909DL2018PTC336828.
Subzone Pharmaceuticals Private Limited is headquartered at Plot No. 20, Kh. No. 1079, Ground Floor Prem Nagar-2, Blk-N, Suleman Nagar,, New Delhi, Delhi, 110086.
Subzone Pharmaceuticals Private Limited was incorporated on 20 July 2018.
The current directors of Subzone Pharmaceuticals Private Limited are
The primary industry of Subzone Pharmaceuticals Private Limited is Trading.
Subzone Pharmaceuticals Private Limited is unlisted.
The authorized capital of Subzone Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.50 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX